Does dosing frequency of anti-CD20 therapies blunt vaccine responses and increase COVID-19 susceptibility in patients with multiple sclerosis?

被引：0
|
作者：
Avasarala, Jagannadha [1 ]
机构：
[1] Univ Kentucky Med Ctr, Dept Neurol, 740 S Limestone, Lexington, KY 40536 USA
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2024年 / 90卷 / 12期
关键词：
Anti-CD20; drugs; B cell repopulation; CD19 cell counts; COVID; 19; susceptibility; dosing frequency; multiple sclerosis; vaccine response; DEPLETION;
D O I：
10.1111/bcp.16248
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：3094 / 3096
页数：3
相关论文
共 50 条
  • [1] COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
    Meca-Lallana, Virginia
    Aguirre, Clara
    Rio, Beatrizdel
    Cardenoso, Laura
    Alarcon, Teresa
    Vivancos, Jose
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
  • [2] Response to COVID-19 mRNA Vaccination in Patients with Multiple Sclerosis on anti-CD20 Disease Modifying Therapies
    Wolf, Andrew
    Pratt, Robert W.
    Crooks, Kristy
    Borko, Tyler
    Gonzalez, Jose Parra
    Vollmer, Timothy
    Frazer-Abel, Ashley
    ANNALS OF NEUROLOGY, 2021, 90 : S179 - S180
  • [3] Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy
    De Oliveira, Antonia
    Lei, Joyce
    Liu, Jiayuan
    Roche, Morgan
    Lin, Jerry
    Alfonso, Roberto
    Sadiq, Saud
    NEUROLOGY, 2023, 100 (17)
  • [4] Anti-CD20 disease modifying therapies decrease the humoral response to COVID-19 mRNA vaccination in patients with multiple sclerosis
    Wolf, A.
    Pratt, R.
    Crooks, K.
    Borko, T.
    Gonzalez, J. Parra
    Vollmer, T.
    Frazer-Abel, A.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 581 - 581
  • [5] Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study
    Moser, Tobias
    O'Sullivan, Ciara
    Otto, Ferdinand
    Hitzl, Wolfgang
    Pilz, Georg
    Schwenker, Kerstin
    Mrazek, Cornelia
    Haschke-Becher, Elisabeth
    Trinka, Eugen
    Wipfler, Peter
    Harrer, Andrea
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2022, 15
  • [6] Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
    Januel, Edouard
    Hajage, David
    Labauge, Pierre
    Maillart, Elisabeth
    De Seze, Jerome
    Zephir, Helene
    Pelletier, Jean
    Guilloton, Laurent
    Bensa, Caroline
    Heinzlef, Olivier
    Casez, Olivier
    Biotti, Damien
    Bourre, Bertrand
    Vukusic, Sandra
    Maurousset, Aude
    Berger, Eric
    Laplaud, David
    Lebrun-Frenay, Christine
    Dubessy, Anne-Laure
    Branger, Pierre
    Thouvenot, Eric
    Clavelou, Pierre
    Sellal, Francois
    Manchon, Eric
    Moreau, Thibault
    Papeix, Caroline
    Tubach, Florence
    Louapre, Celine
    JAMA NETWORK OPEN, 2023, 6 (06) : E2319766
  • [7] A personalized approach for anti-CD20 therapies in multiple sclerosis
    Hogenboom, Laura
    Kempen, Zoe L. E. van
    Kalincik, Tomas
    Bar-Or, Amit
    Killestein, Joep
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 91
  • [8] Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 41
  • [9] Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications
    Moser, T.
    Otto, F.
    Pilz, G.
    Wipfler, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 395 - 395
  • [10] Humoral response to COVID-19 variants in people with Multiple Sclerosis: Impact of Anti-CD20 Therapy
    Shawe-Taylor, Marianne
    Greenwood, David
    He, Anna
    Hobbs, Agnieszka
    Dowgier, Giulia
    Penn, Rebecca
    Sanderson, Theo
    Stevenson-Leggett, Phoebe
    Bazire, James
    Harvey, Ruth
    Champsas, Dimitrios
    Aojula, Anuriti
    Bianchi, Alessia
    Al-Araji, Sarmad
    Hacohen, Yael
    Kassiotis, George
    Gamblin, Steve
    Lewis, Nicola
    Williams, Bryan
    Swanton, Charles
    Gandhi, Sonia
    Bauer, David
    Wu, Mary
    Carr, Edward
    Wall, Emma
    Ciccarelli, Olga
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 505 - 506
12345